BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shahmohammadi S, Doosti R, Shahmohammadi A, Azimi A, Sahraian MA, Fattahi MR, Naser Moghadasi A. Neuromyelitis optica spectrum disorder (NMOSD) associated with cancer: A systematic review. Mult Scler Relat Disord 2021;56:103227. [PMID: 34536774 DOI: 10.1016/j.msard.2021.103227] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Fang W, Tang JL, Lin B, Lai QL, Cai MT, Liu ZR, Zhang YX. Aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder with cholangiocarcinoma: Casual or causal association? CNS Neurosci Ther 2023;29:749-51. [PMID: 36525471 DOI: 10.1111/cns.14042] [Reference Citation Analysis]
2 Nishiyama S, Wright AE, Lotan I, Mikami T, Paul F, Aoki M, Levy M. Upregulated complement receptors correlate with Fc gamma receptor 3A-positive natural killer and natural killer-T cells in neuromyelitis optica spectrum disorder. J Neuroinflammation 2022;19:296. [PMID: 36503481 DOI: 10.1186/s12974-022-02661-1] [Reference Citation Analysis]
3 Duan Y, Wang X, Duan X, Gao H, Ji X, Xiao X, Zhu F, Xue Q. Neuromyelitis optica spectrum disorders associated with AQP4-positive-cancer—A case series. Front Neurol 2022;13. [DOI: 10.3389/fneur.2022.1071519] [Reference Citation Analysis]
4 Apiraksattayakul N, Songwisit S, Owattanapanich W, Tisavipat N, Siritho S, Prayoonwiwat N, Rattanathamsakul N, Jitprapaikulsan J. AQP4-IgG-positive neuromyelitis optica spectrum disorder and temporally detected neoplasms: case report and systematic review. Mult Scler Relat Disord 2022;68:104212. [PMID: 36242805 DOI: 10.1016/j.msard.2022.104212] [Reference Citation Analysis]
5 Goudsmit A, Brandao M, Oullai A, Engelman D, Ghorra N, Daif T, Buelens T, Meert A. Optic neuritis in lung adenocarcinoma: A challenging diagnosis. Respiratory Medicine and Research 2022;82:100966. [DOI: 10.1016/j.resmer.2022.100966] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Molazadeh N, Bose G, Lotan I, Levy M. Autoimmune diseases and cancers overlapping with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): A systematic review. Mult Scler J Exp Transl Clin 2022;8:20552173221128170. [PMID: 36311694 DOI: 10.1177/20552173221128170] [Reference Citation Analysis]
7 Nishiyama S, Wright AE, Lotan I, Mikami T, Paul F, Aoki M, Levy M. Upregulated complement receptors correlate with Fc gamma receptor 3A-positive natural killer and natural killer-T cells in neuromyelitis optica spectrum disorder.. [DOI: 10.21203/rs.3.rs-2143780/v1] [Reference Citation Analysis]
8 Szewczyk AK, Papuć E, Mitosek-szewczyk K, Woś M, Rejdak K. NMOSD—Diagnostic Dilemmas Leading towards Final Diagnosis. Brain Sciences 2022;12:885. [DOI: 10.3390/brainsci12070885] [Reference Citation Analysis]
9 Huang W, Tan H, Xia J, Li W, Li X, ZhangBao J, Chang X, Wang L, Wang M, Zhao C, Lu J, Lu C, Dong Q, Zhou L, Quan C; Pan-Yangtze River Delta Alliance for Demyelinating Disease. The description of neuromyelitis optica spectrum disorder: Patient registry in Yangtze River Delta area of China. Mult Scler Relat Disord 2022;66:104023. [PMID: 35843144 DOI: 10.1016/j.msard.2022.104023] [Reference Citation Analysis]
10 Maiorca C, Moret F, Martines V, Tramontano D, Papassifachis MA, Bini S, Caramazza C, Fontana M, Lucia P, Inghilleri M. Paraneoplastic Neuromyelitis Optica Spectrum Disorder Associated With Lung Adenocarcinoma: A Case Report. Front Med 2022;8:743798. [DOI: 10.3389/fmed.2021.743798] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Mahler JV, de Brito MH, Miyahara-felipe L, Ayres AS, Araújo HA, Silva GD. Paraneoplastic AQP-4 IgG negative neuromyelitis optica spectrum disorder (NMOSD) associated with large-cell high-grade undifferentiated carcinoma of unknown primary site: A case report and review of paraneoplastic NMOSD. Neuroimmunology Reports 2022;2:100110. [DOI: 10.1016/j.nerep.2022.100110] [Reference Citation Analysis]